Stewart Goldman, MD

Division Head, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; Meryl Suzanne Weiss Distinguished Professor in Hematology, Oncology and Stem Cell Transplantation

Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Director, Center for Clinical Trials Research; Co-director, Falk Brain Tumor Center, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Brain tumors (neuro-oncology), cancer survivorship, phase I/phase II developmental therapeutics, clinical trials development

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Programs & Conditions:

Brain Tumor Program

Education & Training

Education: Loyola University Stritch School of Medicine, 1985

Postgraduate Training: University of Chicago Hospitals/Wyler Children's Hospital, 1992, 1988, 1986

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Research

Research Interests: Brain tumors

Publications

Most recent publications

HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma Sci Rep8 (1): 1211
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model J Neurooncol136 (3): 475-484
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee Neuro Oncol20 (1): 13-23
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study J Neurooncol129 (3): 443-51
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas J Neurooncol127 (1): 53-61
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study Pediatr Blood Cancer60 (4): 627-32
Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma PLoS One6 (10): e25114
Efficacy of interstitial continuous vincristine infusion in a bioluminescent rodent intracranial tumor model J Neurooncol106 (2): 261-70
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study J Clin Oncol29 (26): 3529-34
Efficacy of vincristine administered via convection-enhanced delivery in a rodent brainstem tumor model documented by bioluminescence imaging Childs Nerv Syst28 (4): 565-74

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

5 Results

A Virus, a Gene and a Pill Used to Harness the Immune System to Fight Brain Tumor in Children

Children's Research Fund: Advancing discovery for 25 years

Why Drew's Family Runs for Brain Tumor Research

Double Diagnosis: Quest for a Cure for Talia & Anthony

From Surviving to Thriving

See all News & Stories >